Koninklijke Philips (NYSE:PHG) Rating Lowered to “Hold” at StockNews.com

StockNews.com cut shares of Koninklijke Philips (NYSE:PHG) from a buy rating to a hold rating in a research report released on Thursday.

Separately, Jefferies Financial Group upgraded Koninklijke Philips from an “underperform” rating to a “hold” rating in a research report on Tuesday, October 29th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Koninklijke Philips Price Performance

Koninklijke Philips stock opened at $25.84 on Thursday. The firm has a market capitalization of $24.29 billion, a PE ratio of -61.52, a price-to-earnings-growth ratio of 0.91 and a beta of 0.77. Koninklijke Philips has a 12-month low of $19.49 and a 12-month high of $32.91. The firm has a 50-day moving average price of $30.05 and a 200-day moving average price of $28.29. The company has a current ratio of 1.16, a quick ratio of 0.74 and a debt-to-equity ratio of 0.60.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. Allspring Global Investments Holdings LLC bought a new position in Koninklijke Philips in the 1st quarter worth about $40,000. Fairscale Capital LLC purchased a new position in Koninklijke Philips during the 2nd quarter worth $54,000. CWM LLC raised its position in Koninklijke Philips by 21.9% during the 2nd quarter. CWM LLC now owns 3,429 shares of the technology company’s stock valued at $86,000 after purchasing an additional 616 shares in the last quarter. Eastern Bank bought a new stake in Koninklijke Philips during the 3rd quarter valued at $88,000. Finally, Headlands Technologies LLC purchased a new stake in shares of Koninklijke Philips in the 1st quarter worth $91,000. Hedge funds and other institutional investors own 13.67% of the company’s stock.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.